Rajiv Mohan, MS, PhD, a professor of ophthalmology and molecular medicine in the CVM, was recently awarded three separate grants totaling more than $2 million for ongoing research. The National Institutes of Health funded two grants with the third awarded by the United States Department of Veterans Affairs.
The first award from the NIH supports Mohan’s research as a co-investigator on diabetic retinopathy. The title of the research is, “The Role of S100 Proteins in Diabetic Retinopathy.” This grant provides $500,000 in funding. The second NIH award totaling $429,000 is for Mohan’s research as a co-principal investigator on chemical toxicity to the eye. The title of this research is, “Hydrogen Sulfide Toxicity to the Cornea.”
The third award, a Veterans Affairs Merit Grant, will fund development of nanomedicine for treating corneal scarring. The title of this research is, “Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases.” The grant provides funding of $1.1 million beginning in October.
By Nick Childress